Stryker Corporation (SYK) traded with a cut of -0.41 points or -0.33% at $123.12 per share. As per the last available information, the stock aggregated $57.66 million in upticks and $35.69 million in downticks, keeping the net money flow capped at $21.97 million. The up/down ratio was found to be 1.62. For the week, the shares has seen a change of -0.14% in the share price.A block trade of $27.77 million in upticks and $7.4 million in downticks also took place during the day. The up/down ratio for the block stood at 3.75. The net money flow for this transaction was $20.37 million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Shares of Stryker Corporation rose by 1.66% in the last five trading days and 2.76% for the last 4 weeks. Stryker Corporation is up 7.11% in the last 3-month period. Year-to-Date the stock performance stands at 2.76%. Stryker Corporation (NYSE:SYK) witnessed a decline in the market cap on Wednesday as its shares dropped 0.33% or 0.41 points. After the session commenced at $123.43, the stock reached the higher end at $123.82 while it hit a low of $122.42. With the volume soaring to 1,586,901 shares, the last trade was called at $123.12. The company has a 52-week high of $127.23. The company has a market cap of $46,102 million and there are 374,451,720 shares in outstanding. The 52-week low of the share price is $94.31.
Company has reported several Insider transactions to the SEC, on Jan 31, 2017, Louise Francesconi (director) sold 3,716 shares at 122.34 per share price.On Jan 5, 2017, Yin C Becker (VP, Comm. and Public Affairs) sold 11,660 shares at 120.22 per share price.On Dec 28, 2016, Ronda E Stryker (director) sold 5,194 shares at 120.60 per share price.
Stryker Corporation Last issued its quarterly earnings results on Jan 24, 2017. The company reported $1.78 EPS for the quarter, beating the analyst consensus estimate by $ 0.02. Analyst had a consensus of $1.76. The company had revenue of $3157.00 million for the quarter, compared to analysts expectations of $3148.44 million. The companys revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Company shares were Reiterated by Canaccord Genuity on Jan 25, 2017 to Buy, Raises Price Target to $ 137 from a previous price target of $127 .Stryker Corporation was Downgraded by Needham to Underperform on Jan 6, 2017.
Stryker Corporation develops, manufactures, and markets specialty surgical and medical products, including orthopaedic implants, bone cement, trauma systems used in bone repair, powered surgical instruments, endoscopic systems, craniomaxillofacial fixation devices, specialty surgical equipment used in neurosurgery and patient care and handling equipment for the global market and provide outpatient physical and occupational rehabilitation services.